Company: CGCT
Filing Date: 2025-03-21
Form Type: S-1/A
Source: 0001104659-25-026623
Chunk: 278

Company: Cartesian Growth Corp III
Filing Date: 2025-03-21
Form: S-1/A
Chunk 278
---
 be reduced as specified in the warrant agreement based on the Black-Scholes Warrant Value (as defined in the warrant agreement)
of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary
transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive
the full potential value of the warrants.

The warrants will be issued in registered form
under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement
provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity
or to correct any defective provision or mistake, including to conform the provisions of the warrant agreement to the description of
the terms of the warrants and the warrant agreement set forth in this prospectus, (ii) adjusting the provisions relating to cash
dividends on ordinary shares as contemplated by and in accordance with the warrant agreement, (iii) adding or changing any provisions
with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or
desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants or (iv) to provide
for the delivery of the Alternative Issuance. All other modifications or amendments require the vote or written consent the holders of
at least 50% of the then-outstanding public warrants, except that amending our warrant agreement will require a vote of holders of at
least 50% of the private placement warrants (including the vote in favor or written consent of Cantor) or private placement-equivalent
warrants that may be issued upon conversion of working capital loans solely with respect to any amendment to the terms of the private
placement warrants or private placement-equivalent warrants that may be issued upon conversion of working capital loans (including, for
the avoidance of doubt, the forfeiture or cancellation of any warrants). You should review a copy of the warrant agreement, which is
filed as an exhibit to the registration statement of which this prospectus forms a part, for a complete description of the terms and
conditions applicable to the warrants.

<div align='center'>144</div>

The warrants may be exercised upon surrender
of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by